Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia (Q43633624)

25 November 2017

Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia (English)

1 reference

25 November 2017

1 reference

1 reference

1 reference

D P Nicolau

1

1 reference

25 November 2017

J McNabb

2

1 reference

25 November 2017

M K Lacy

3

1 reference

25 November 2017

R Quintiliani

4

1 reference

25 November 2017

C H Nightingale

5

1 reference

25 November 2017

1 June 2001

1 reference

International Journal of Antimicrobial Agents

25 November 2017

1 reference

25 November 2017

17

1 reference

25 November 2017

6

1 reference

25 November 2017

497-504

1 reference

Epidemiology and control of nosocomial infections in adult intensive care units

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Hospital-acquired pneumonia: epidemiology, etiology, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Once-daily aminoglycoside therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

CDC definitions for nosocomial infections, 1988

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

The diagnosis and treatment challenges in nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

"Continuous" vs. "discontinuous" therapy with penicillin; the effect of the interval between injections on therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Continuous infusion of beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

A randomized trial of cefepime (BMY-28142) and ceftazidime for the treatment of pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Low-dose continuous-infusion ceftazidime monotherapy in low-risk febrile neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

A pilot study of the efficacy of constant-infusion ceftazidime in the treatment of endobronchial infections in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Intermittent and continuous ceftazidime infusion for critically ill trauma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Continuous infusion of ceftazidime in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Continuous infusion of ceftazidime in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Cure of Pseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Intermittent bolus dosing of ceftazidime in critically ill patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Continuous infusion ceftazidime in intensive care: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

10.1016/S0924-8579(01)00329-6

Identifiers

DOI

1 reference

25 November 2017

1 reference